Ketoconazole and LGD-4033 Interaction
Ketoconazole and LGD-4033 have an interaction requiring monitoring for interaction with 51% confidence. Both Ketoconazole and LGD-4033 carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. These compounds primarily affect different organ systems.
Compound Profiles
Ketoconazole
Antifungal | Topical Anti-Androgen for Hair Loss
Ketoconazole works through multiple pathways relevant to hair loss. As an azole antifungal, it inhibits the enzyme lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis and killing Malassezia fungi that colonize the scalp and contribute to inflammation and seborrheic dermatitis.
View full profileLGD-4033
Selective Androgen Receptor Modulator | Lean Mass
LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Ketoconazole with LGD-4033?
Yes, but with caution. Both Ketoconazole and LGD-4033 carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. Regular monitoring is advised.
Is Ketoconazole and LGD-4033 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic. Monitor accordingly.
What are the interactions between Ketoconazole and LGD-4033?
Both Ketoconazole and LGD-4033 carry androgenic activity. Additive androgenic load increases risk of acne, hair loss, and prostate effects. Monitor for dose-dependent side effects. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.
How should I time Ketoconazole and LGD-4033?
Ketoconazole has a half-life of Topical application stays local with minimal systemic absorption and LGD-4033 has a half-life of ~24-36 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.